Study details
Enrolling now
Bone in CKD Alkali Response (BICARb) Trial
Albert Einstein College of Medicine
NCT IDNCT05918029ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2/3
Target enrollment
103
Study length
about 2 years
Ages
5–100
Locations
2 sites in NY, PA
About this study
Researchers are testing whether potassium citrate improves bone health in people with chronic kidney disease. The trial will compare the effects of potassium citrate to a placebo on bone quality and strength, as well as investigate how potassium citrate affects bones. Participants will provide blood samples and undergo advanced bone imaging during it.
Based on ClinicalTrials.gov records.
What participants do
- 1.Placebo
- 2.Take Potassium Citrate Extended Release Oral Tablet
- 3.Take Potassium Citrate and Citric Acid Oral Solution
PhasePhase 2/Phase 3
DrugCitric Acid Oral Solution
Routetopical
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low13%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
ALIMENTARY TRACT AND METABOLISM, potassium citrate
Drug routes
topical, oral (Oral Capsule), oral
Body systems
Renal, Musculoskeletal